[Pharmacokinetic aspects of a pyrimethamine combination with sulfanilamides].
D000818:Animals; D000962:Antimalarials / Q000378:metabolism; D004338:Drug Combinations / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008288:Malaria / Q000378:metabolism; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000378:metabolism*; D013413:Sulfadoxine / Q000378:metabolism; D013415:Sulfalene / Q000378:metabolism; D013424:Sulfanilamides / Q000378:metabolism*; D013997:Time Factors
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; C050416:metakelfin; D013413:Sulfadoxine; D013415:Sulfalene; D011739:Pyrimethamine
Farmakokineticheskie aspekty kombinirovaniia pirimetamina s sul'fanilamidami.